Sleep Science Friday: The burden of polypharmacy in sleep disorders

Sleep Science Friday: The burden of polypharmacy in sleep disorders 

05 February 2021

Knowledge of pharmacokinetics and pharmacodynamics is essential to the understanding of potential drug-drug interactions and their consequences. We invite you to watch the e-lesson on the effects of pharmacological agents on sleep and vigilance given by Prof.Tarja Porkka-Heiskanen. You will learn about the brain-related factors which affect the drug effects, mechanisms of neurotransmission, and vigilance-related side effects of commonly used medications.

Vimeo

By loading the video, you agree to Vimeo's privacy policy.
Learn more

Load video

Polypharmacy, defined as the use of multiple (or even excessive and unjustified) medication is one of the challenges of modern medicine. It is very frequent in comorbid and elderly patients (Patel P. et al. 2017  ) and was shown to be associated with adverse effects and drug-drug interactions. The latter includes pharmacokinetic (an interaction at the level of absorption, distribution, metabolism, and/or excretion) and pharmacodynamic (an additive interaction or a counteraction at the level of receptor sites) interactions (Palleria C. et al. 2013).  Both types of drug-drug interactions were shown to occur frequently (exceeding 50%) with drugs used to treat psychiatric pathology, seizures and sleep disorders (Nelson S. et al. 2014  ), and with the inappropriate use of sedatives and hypnotics in particular.  

No less important is the understanding of the impact of sleep-related medications on brain function and sleep parameters in comorbid patients. The Journal of Sleep Research has recently published a collaborative Swiss-German randomised, double‐blind, placebo‐controlled crossover study which assessed the safety of the sedative medication Daridorexant in patients with comorbid chronic obstructive pulmonary disease and insomnia (Boof M. et al. 2021). The authors demonstrated that Daridorexantcan be safely used as it does not impair nocturnal respiratory function and improves sleep parameters. The identification of clinically significant drug-drug interactions and their proper management are a necessary step to prevent deleterious consequences. Deprescribing these drugs are one of the approaches to decrease the burden of polypharmacy and, in particular, of the inappropriate use of drugs (Pottie K. et al. 2018Bjerre L. et al, 2018 ;  Lee J et al. 2019 ). The approaches should be flexible, individualized, and include a gradual taper according to a developed plan, assessment of favourable predictors and psychological factors (Allary A et al. 2020 ), perceived barriers and facilitators (Kuntz J. et al. 2018 ), specific education provided by medical doctors, nurses (Reynolds J. et al. 2020 ), leaflets (Wilson M et al. 2018  ), pharmacists (Kuntzet al, 2019 ), social support, active engagement of patients and caregivers (Garfinkel D. 2018 ), as well as GPs (Carrier H. et al. 2019 ), physical medicine methods (Geller A. et al. 2012), lifestyle interventions (Martinez-Gomez et al., 2018 ) and close monitoring. Behavioral therapies alone or cognitive behavioral therapy (CBT) were shown to be highly helpful (Hintze et al. 2020). The combination of different methods shows higher efficacy and safety (Reeve E. et al, 2017 ) and leads to a decrease in adverse effects and drug-drug interactions (Garfinkel D., 2018 ).

You can learn more about CBT in insomnia, and find news from the European Academy for Cognitive-Behavorial Treatment of Insomnia here

Recent publications from the ESRS members: 

  1. DelRosso,Mogavero and Ferri (2021) Restless Sleep Disorder, Restless Legs Syndrome and Periodic Limb movement Disorder – Sleep in Motion! Pediatr Pulmonol.
  2. Alventeet al. (2021) . Autonomic Mechanisms Of Blood Pressure Alterations During Sleep In Orexin/Hypocretin-Deficient Narcoleptic MiceSleep.
  3. SvedmyrS et al. (2021). Superior hypertension control with betablockade in the European Sleep Apnea DatabaseHypertens.
  4. RaposoD et al. (2021). Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea. Otolaryngol Head Neck Surg.
  5. Santoso et al. (2021)  Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factorsSupport Care Cancer.

Just published an article? Want your research to be featured? Saw something interesting? Contact us at ESRS 

Do not miss the date! Subscribe for the 2021 Examination in Sleep Medicine to become a certified expert in sleep medicineThe on-line application is already open on this website.

Not a member yet? Apply here and see our wide range of benefits, including a yearly online subscription to the Journal of Sleep Research, automatic membership to the Federation of European Neuroscience Societies (FENS), support for early career researchers via the ECRN, regular updates via the ESRS Newsletter, promotion of your research, and more.   

 

ESRS

For further information about the ESRS,
please contact the ESRS Office:

Günzstr. 4
93059 Regensburg
Germany

Email:
vroni.aumeier@esrs.eu

Phone: +49 941 89939875
Fax: +49 941 89939877

VAT ID no.:DE306025081
Register no. of associations: VR 1646 AG Regensburg
Vereinsregister: VR 1646 AG Regensburg

top
X